BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23077237)

  • 1. Compatibility of the repairable-conditionally repairable, multi-target and linear-quadratic models in converting hypofractionated radiation doses to single doses.
    Iwata H; Matsufuji N; Toshito T; Akagi T; Otsuka S; Shibamoto Y
    J Radiat Res; 2013 Mar; 54(2):367-73. PubMed ID: 23077237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses: an in vitro study.
    Iwata H; Shibamoto Y; Murata R; Tomita N; Ayakawa S; Ogino H; Ito M
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):482-8. PubMed ID: 19735872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor.
    Otsuka S; Shibamoto Y; Iwata H; Murata R; Sugie C; Ito M; Ogino H
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1538-43. PubMed ID: 22115556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applicability of the linear-quadratic model to single and fractionated radiotherapy schedules: an experimental study.
    Miyakawa A; Shibamoto Y; Otsuka S; Iwata H
    J Radiat Res; 2014 May; 55(3):451-4. PubMed ID: 24351457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy.
    Cui M; Gao XS; Li X; Ma M; Qi X; Shibamoto Y
    Radiat Oncol; 2022 Mar; 17(1):54. PubMed ID: 35303922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy.
    Guerrero M; Li XA
    Phys Med Biol; 2004 Oct; 49(20):4825-35. PubMed ID: 15566178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative analysis of radiobiological models for cell surviving fractions at high doses.
    Andisheh B; Edgren M; Belkić D; Mavroidis P; Brahme A; Lind BK
    Technol Cancer Res Treat; 2013 Apr; 12(2):183-92. PubMed ID: 23098282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized Multi-Hit Model of Radiation-Induced Cell Survival with a Closed-Form Solution: An Alternative Method for Determining Isoeffect Doses in Practical Radiotherapy.
    Zhao L; Chen X; Tian J; Shang Y; Mi D; Sun Y
    Radiat Res; 2020 Apr; 193(4):359-371. PubMed ID: 32031917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data.
    Ohri N; Dicker AP; Lawrence YR
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):385-93. PubMed ID: 22265460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
    Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
    Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters.
    Borst GR; Ishikawa M; Nijkamp J; Hauptmann M; Shirato H; Bengua G; Onimaru R; de Josien Bois A; Lebesque JV; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1596-603. PubMed ID: 20231066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of hypersensitivity to fractionated low-dose radiation exposure.
    Smith LG; Miller RC; Richards M; Brenner DJ; Hall EJ
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):187-91. PubMed ID: 10477023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the dose- and time-dependence of the induction of different types of cell death in a small‑cell lung cancer cell line: Implementation of the repairable-conditionally repairable model.
    Makris N; Edgren M; Mavroidis P; Lind BK
    Int J Oncol; 2013 Jun; 42(6):2019-27. PubMed ID: 23588899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obtaining organ-specific radiobiological parameters from clinical data for radiation therapy planning of head and neck cancers.
    Quashie EE; Li XA; Prior P; Awan M; Schultz C; Tai A
    Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37903437
    [No Abstract]   [Full Text] [Related]  

  • 15. Revisiting the formalism of equivalent uniform dose based on the linear-quadratic and universal survival curve models in high-dose stereotactic body radiotherapy.
    Chan MKH; Chiang CL
    Strahlenther Onkol; 2021 Jul; 197(7):622-632. PubMed ID: 33245378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the LQ model with large fraction sizes results in underestimation of isoeffect doses.
    Sheu T; Molkentine J; Transtrum MK; Buchholz TA; Withers HR; Thames HD; Mason KA
    Radiother Oncol; 2013 Oct; 109(1):21-5. PubMed ID: 24060173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation.
    Astrahan M
    Med Phys; 2008 Sep; 35(9):4161-72. PubMed ID: 18841869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fitting the Generalized Target Model to Cell Survival Data of Proton Radiation Reveals Dose-Dependent RBE and Inspires an Alternative Method to Estimate RBE in High-Dose Regions.
    Zhao L; He X; Chen X; Shang Y; Mi D; Sun Y
    Radiat Res; 2019 Nov; 192(5):507-516. PubMed ID: 31418641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model.
    Shibamoto Y; Otsuka S; Iwata H; Sugie C; Ogino H; Tomita N
    J Radiat Res; 2012; 53(1):1-9. PubMed ID: 21997195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A unified multi-activation (UMA) model of cell survival curves over the entire dose range for calculating equivalent doses in stereotactic body radiation therapy (SBRT), high dose rate brachytherapy (HDRB), and stereotactic radiosurgery (SRS).
    Li S; Miyamoto C; Wang B; Giaddui T; Micaily B; Hollander A; Weiss SE; Weaver M
    Med Phys; 2021 Apr; 48(4):2038-2049. PubMed ID: 33590493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.